Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells

Parthasarathy Rangarajan; Dharmalingam Subramaniam; Santanu Paul; Deep Kwatra; Kanagaraj Palaniyandi; Shamima Islam; Sitaram Harihar; Satish Ramalinagam; William Gutheil; Sandeep Putty; Rohan Pradhan; Subhash Padhye; Danny R. Welch; Shrikant Anant; Animesh Dhar

doi:10.18632/oncotarget.4871

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells

Parthasarathy Rangarajan _, Dharmalingam Subramaniam, Santanu Paul, Deep Kwatra, Kanagaraj Palaniyandi, Shamima Islam, Sitaram Harihar, Satish Ramalinagam, William Gutheil, Sandeep Putty, Rohan Pradhan, Subhash Padhye, Danny R. Welch, Shrikant Anant and Animesh Dhar

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:27661-27673. https://doi.org/10.18632/oncotarget.4871

Metrics: PDF 2668 views | HTML 4338 views | ?

Abstract

Parthasarathy Rangarajan2, Dharmalingam Subramaniam2, Santanu Paul1, Deep Kwatra2, Kanagaraj Palaniyandi1, Shamima Islam1, Sitaram Harihar1, Satish Ramalingam2, William Gutheil3, Sandeep Putty3, Rohan Pradhan4, Subhash Padhye4, Danny R. Welch1,2, Shrikant Anant1,2, Animesh Dhar1,2

1Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA

2Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA

3Department of Pharmaceutical Sciences, University of Missouri at Kansas City, Kansas City, MO, USA

4Interdisciplinary Science and Technology Research Academy, Abeda Inamdar College, University of Pune, Pune, India

Correspondence to:

Animesh Dhar, e-mail: [email protected]

Keywords: crocetin, nude mice, pancosphere, DCLK-1, gli transcription factor

Received: April 02, 2015 Accepted: July 31, 2015 Published: August 13, 2015

ABSTRACT

Pancreatic cancer is the fourth leading cause of cancer deaths in the US and no significant treatment is currently available. Here, we describe the effect of crocetinic acid, which we purified from commercial saffron compound crocetin using high performance liquid chromatography. Crocetinic acid inhibits proliferation of pancreatic cancer cell lines in a dose- and time-dependent manner. In addition, it induced apoptosis. Moreover, the compound significantly inhibited epidermal growth factor receptor and Akt phosphorylation. Furthermore, crocetinic acid decreased the number and size of the pancospheres in a dose-dependent manner, and suppressed the expression of the marker protein DCLK-1 (Doublecortin Calcium/Calmodulin-Dependent Kinase-1) suggesting that crocetinic acid targets cancer stem cells (CSC). To understand the mechanism of CSC inhibition, the signaling pathways affected by purified crocetinic acid were dissected. Sonic hedgehog (Shh) upon binding to its cognate receptor patched, allows smoothened to accumulate and activate Gli transcription factor. Crocetinic acid inhibited the expression of both Shh and smoothened. Finally, these data were confirmed in vivo where the compound at a dose of 0.5 mg/Kg bw suppressed growth of tumor xenografts. Collectively, these data suggest that purified crocetinic acid inhibits pancreatic CSC, thereby inhibiting pancreatic tumorigenesis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4871

Publication Alerts

Research Papers:

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells

Abstract